Results 181 to 190 of about 24,477,013 (226)

Design and synthesis of thiadiazoles as anticancer, apoptotic, and VEGFR-2 inhibitors. [PDF]

Future Med Chem
Elgammal WE, Elkady H, Dahab MA, Mahdy HA, Hagras M, Nofal A, Alsfouk BA, Elkaeed EB, Eissa IH, Metwaly AM.   +9 more
europepmc   +1 more source

Advances in therapeutic approaches to gastric cancer

CA: A Cancer Journal for Clinicians, Volume 76, Issue 5, September/October 2026.
Abstract Gastric cancer remains a leading cause of cancer‐related mortality worldwide, with nearly 1 million new cases diagnosed annually. Despite innovations in diagnosis, most patients still present at advanced stages, contributing to a poor prognosis.
Feng Wang, Zi‐Xian Wang, Yu‐Jing Zhang, Ye He, Jia‐Fu Ji, Yuan‐Fang Li, Xiu‐Juan Qu, Yi Ba, Shu‐Qiang Yuan, Rui‐Hua Xu   +9 more
wiley   +1 more source

RETRACTION: Licoflavone A Suppresses Gastric Cancer Growth and Metastasis by Blocking the VEGFR-2 Signaling Pathway. [PDF]

J Oncol
Oncology JO.
europepmc   +1 more source

Antiproliferation, 3D-multicellular spheroid and VEGFR-2 inhibitory properties of spiroindolin-2-ones with phosphonate function. [PDF]

Sci Rep
Hassan SM, Farid A, Bekheit MS, Panda SS, Kariuki BM, Abdelnaser A, Nasr S, Fayad W, El-Manawaty MA, Soliman AAF, Girgis AS.   +10 more
europepmc   +1 more source

Novel Sulfonamide Derivatives as Anticancer Agents, VEGFR‑2 Inhibitors, and Apoptosis Triggers: Design, Synthesis, and Computational Studies. [PDF]

ACS Omega
Al-Ziyadi SH, Halawa AH, Belal A, Albezrah NKA, Obaidullah AJ, Abdelshafi NS, Al-Shareef HF, Mehany ABM, Hassan SM, Elgammal WE.   +9 more
europepmc   +1 more source

Multimodal characterization of a pyrazolo[3,4-<i>b</i>]pyridine aldehyde: quantum chemical insights, NLO activity and VEGFR-2 docking/molecular dynamics. [PDF]

RSC Adv
Acosta-Quiroga K, Jiménez CA, Cobos-Montes K, Rodríguez-Núñez YA, López J, Guerra C, Calderón Orjuela DA, Gutierrez M, Polo-Cuadrado E.   +8 more
europepmc   +1 more source

Exceptional therapeutic benefit of imatinib in cKIT‐mutated mucosal melanoma followed by a KIT mutation loss

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page 1311-1313, September 2026.
Hannah Zillikens, Corinna Scheib, Vicky Peller, Christina Müller, Sebastian Bauer, Ina Pretzell, Klaus Griewank, Antje Sucker, Eva Hadaschik, Felicitas Guntrum, Sven Holger Baum, Alexander Roesch, Selma Ugurel, Dirk Schadendorf, Lisa Zimmer, Elisabeth Livingstone   +15 more
wiley   +1 more source

Pyrazolo[3,4-<i>d</i>]pyrimidine derivatives as VEGFR-2 and EGFR^T790M dual inhibitors: design, docking, ADMET, synthesis and anticancer evaluations. [PDF]

RSC Adv
Aziz NAAM, George RF, Nasr T, El-Adl K, Elmasry GF.   +4 more
europepmc   +1 more source

Development of the 5‑Nitrosalicaldehyde Arylhydrazones as Anticancer (MCF‑7 and HCT116) Agents Targeting Inhibition of VEGFR‑2 and Cytokines (IL‑6 and TNF-α). [PDF]

ACS Omega
Nkoana JK, More GK, Elhenawy AA, Mphahlele MJ.   +3 more
europepmc   +1 more source

Ajuforrestin A Inhibits Tumor Proliferation and Migration by Targeting the STAT3/FAK Signaling Pathways and VEGFR-2. [PDF]

Biology (Basel)
Wang S, Li Y, Rong M, Li Y, Lu Y, Li S, Lee D, Xu J, Guo Y.   +8 more
europepmc   +1 more source